Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX)
CUSIP: 03237H101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 109,540,561
- Total 13F shares
- 43,406,257
- Share change
- -104,498
- Total reported value
- $140,608,833
- Put/Call ratio
- 240%
- Price per share
- $3.24
- Number of holders
- 107
- Value change
- +$5,128,506
- Number of buys
- 52
- Number of sells
- 65
Quarterly Holders Quick Answers
What is CUSIP 03237H101?
CUSIP 03237H101 identifies AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03237H101:
Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ALS Invest 1 B.V. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,895,280
|
$96,258,721 | — | 06 Jul 2022 | |
| Morningside Venture Investments Ltd |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,997,302
|
$81,596,447 | — | 15 Aug 2023 | |
| DRAGSA 96 LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,300,000
|
$37,554,630 | — | 11 Jan 2022 | |
| VIKING GLOBAL INVESTORS LP |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,850,940
|
$30,222,333 | — | 08 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
4,223,968
|
$8,025,539 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
3%
|
3,340,943
|
$6,347,793 | — | 30 Jun 2024 | |
| Margaret Olinger |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
320,685
mixed-class rows
|
$5,178,792 | — | 27 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.4%
|
2,669,741
|
$5,072,509 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.4%
|
2,610,420
|
$4,959,798 | — | 30 Jun 2024 | |
| Almitas Capital LLC |
13F
|
Company |
1.7%
|
1,903,851
|
$3,617,317 | — | 30 Jun 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
1.7%
|
1,823,420
|
$3,464,498 | — | 30 Jun 2024 | |
| Patrick D. Yeramian |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
239,375
mixed-class rows
|
$3,357,139 | — | 09 Jan 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
1,535,178
|
$2,916,838 | — | 30 Jun 2024 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.4%
|
1,501,871
|
$2,853,555 | — | 30 Jun 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
1.4%
|
1,500,000
|
$2,850,000 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.2%
|
1,344,818
|
$2,555,154 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.2%
|
1,308,181
|
$2,485,544 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.2%
|
1,297,838
|
$2,465,892 | — | 30 Jun 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,211,617
|
$2,300,000 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.1%
|
1,154,200
|
$2,192,980 | — | 30 Jun 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,150,221
|
$2,185,420 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.84%
|
924,459
|
$1,756,473 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.74%
|
811,488
|
$1,541,827 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.72%
|
789,127
|
$1,499,342 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.61%
|
663,376
|
$1,260,415 | — | 30 Jun 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.57%
|
621,927
|
$1,181,661 | — | 30 Jun 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.54%
|
589,111
|
$1,119,311 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.52%
|
570,857
|
$1,084,628 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.48%
|
523,772
|
$995,167 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
521,619
|
$991,076 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.45%
|
491,107
|
$933,103 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.44%
|
477,524
|
$907,296 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.43%
|
468,866
|
$891,092 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.41%
|
446,038
|
$847,472 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
367,249
|
$697,773 | — | 30 Jun 2024 | |
| AVIVA PLC |
13F
|
Company |
0.33%
|
363,032
|
$689,761 | — | 30 Jun 2024 | |
| Graham Capital Management, L.P. |
13F
|
Company |
0.29%
|
321,867
|
$611,547 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.27%
|
299,691
|
$569,413 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.26%
|
289,281
|
$549,634 | — | 30 Jun 2024 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.25%
|
274,551
|
$521,647 | — | 30 Jun 2024 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.25%
|
272,576
|
$517,894 | — | 30 Jun 2024 | |
| Aldebaran Capital, LLC |
13F
|
Company |
0.25%
|
269,803
|
$512,626 | — | 30 Jun 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.23%
|
250,000
|
$475,000 | — | 30 Jun 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.2%
|
220,517
|
$418,000 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.19%
|
210,612
|
$400,163 | — | 30 Jun 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.17%
|
188,465
|
$358,084 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.16%
|
178,774
|
$339,671 | — | 30 Jun 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.15%
|
166,548
|
$316,441 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.14%
|
154,908
|
$294,325 | — | 30 Jun 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.13%
|
139,097
|
$264,284 | — | 30 Jun 2024 |
Institutional Holders of Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) as of Q3 2024
As of 30 Sep 2024,
Amylyx Pharmaceuticals, Inc. - Common Stock (AMLX) was held by
107 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,406,257 shares.
The largest 10 holders included
TCG Crossover Management, LLC, VANGUARD GROUP INC, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, Alyeska Investment Group, L.P., 683 Capital Management, LLC, Almitas Capital LLC, abrdn plc, CITADEL ADVISORS LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
115
Q3 2024 holders
107
Holder diff
-8
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.